HEALTH Share Price Performance
€2.53
-0.65 (-20.35%)
5.2% overvalued intrinsic discount
€2.40
Fair Value
Price €2.53
AnalystConsensusTarget €2.40
Fair Value€2.40
Share Price€2.53
5.2% overvalued intrinsic discount
Nightingale Health Oyj Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
HEALTH Community Narratives
AN
Fair Value €2.4 5.2% overvalued intrinsic discount
New US And Singapore Labs Will Improve Healthcare Efficiency
1users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
Nightingale Health Oyj Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 05, 2026
- Earnings per share (EPS)
- -0.31
- Gross Margin
- 75.39%
- Net Profit Margin
- -393.37%
- Debt/Equity Ratio
- 0.4%
Nightingale Health Oyj Competitors
Snowflake Analysis
About HEALTH
- Founded
- 2002
- Employees
- 100
- CEO
- WebsiteView website
Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Health Check Remote where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Finnish Market Performance
- 7 Days: 0.07%
- 3 Months: 3.2%
- 1 Year: 8.5%
- Year to Date: 13.9%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 5.8% in that time. More promisingly, the market is up 7.2% over the past year. Earnings are forecast to grow by 17% annually. Market details ›